Skip to content

Study · Not a test of the peptide alone · 1986

1 result

Degradation of luteinizing hormone-releasing hormone (LHRH) and an LHRH agonist by the rat testis.

Hedger MP, Robertson DM, Tepe SJ, Browne CA, de Kretser DM

Molecular and cellular endocrinology1 Jun 1986Cited by 7 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone1

In this study, Oxytocin was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Oxytocin.

  1. 01LabNot a test of Oxytocin aloneIn vitro (cell-free)Mechanism

    In rat testis supernatants, the LHRH-degrading peptidase was inhibited by a group of compounds that included oxytocin.

    In plain wordsIn lab tests with rat testis extract, an enzyme that breaks down LHRH was blocked by several compounds, oxytocin among them.

    Peptide
    Oxytocin
    Outcome
    DecreaseInhibition of LHRH-degrading peptidase
    Study

    ratn: not reported in source

    high-speed supernatants of rat testis
    Outcome group
    Receptor activity and mechanism · Endocrine and hormones

    Source sentences

    Summary
    The peptidase was inhibited by sulphydryl reagents, TLCK, 1,10-phenanthroline, EDTA, bacitracin, other LHRH analogues, oxytocin, [Lys8]vasopressin and somatostatin.
    1 context sentence
    Summary · context
    Degradation of LHRH and [D-Ser(tBu)6,des-Gly-NH10(2)]LHRH ethylamide (LHRH-A), during incubation with high-speed supernatants of rat testes

    In this study, Oxytocin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Oxytocin.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    11 Oct 2026, 20:03 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 02:54 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.